IP Library Granted Patent US 12,414,733
Granted Patent B2
US 12,414,733 · App. 17/019,670 · Granted Sep 16, 2025

Methods and systems for the detection of disease

Inventors: Joseph Michael Lawless Kelly (Duxbury, MA); Joseph Michael Kelly (Duxbury, MA)
Assignee: Joseph Michael Lawless Kelly: Joseph Michael Kelly
A61B5/4064A61B3/0025A61B3/112A61B3/113A61B3/14A61B3/145A61B5/00A61B5/4088A61B5/4866G06T2207/30004G06T2207/30041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,733
App. No.
17/019,670
Granted
Sep 16, 2025
Kind
B2
Abstract

Disclosed herein are systems and methods for the detection of alterations in glucose metabolism in a subject. The disclosed methods and systems provide, in certain embodiments, administering a first eye test to the subject when the subject is in a normal state, obtaining a first set of one or more images of the first eye test of the subject, administering a second eye test to the subject and obtaining a second set of one or more images of the second eye test of the subject. The methods further provide for analyzing one or more differences identified between the first set of one or more images and the second set of one or more images.

Claims (24)

1. A method of detecting an alteration in glucose metabolism in the brain of a subject, the method comprising:

providing a device comprising a processor, an interface, a memory, and a generator of optical stimuli, wherein the optical stimuli causes eyes of the subject to move;

obtaining, using the device, a first set of one or more images characterizing a first change in eye movement of the subject induced by the optical stimuli produced by the generator at a first time when the subject is in a normal state;

obtaining, using the device, a second set of one or more images characterizing a second change in eye movement of the subject induced by the optical stimuli produced by the generator at a subsequent time;

calculating, by the processor of the device, one or more differences between the first set of one or more images and the second set of one or more images, wherein the differences are determined by comparing the first set of one or more images to the second set of one or more images such that a difference between the first change in eye movement and the second change in eye movement is detected; and

indicating, by the processor of the device, an insulin resistant state in the subject based on the calculated one or more differences.

2. The method of claim 1 , wherein a King-Devick Test is administered to the subject using the device at both the first time and the subsequent time.

3. The method of claim 1 further comprising storing the first set of one or more images in a storage medium.

4. The method of claim 1 , wherein the subsequent time is when the subject has performed physical activity after the first time.

5. The method of claim 1 further comprising storing the second set of one or more images in a storage medium.

6. The method of claim 1 , wherein the eye movement includes at least one of a lateral eye movement, a vertical eye movement, a diagonal eye movement, and a dilation of a pupil.

7. The method of claim 1 , wherein the insulin resistant state is indicated, by the processor of the device, when a second dilation of a pupil shown in the second set of one or more images is slowed when compared to a first dilation of the pupil shown in the first set of one or more images.

8. The method of claim 1 , wherein the insulin resistant state is indicated, by the processor of the device, when a second lateral eye movement shown in the second set of one or more images is slowed when compared to a first lateral eye movement shown in the first set of one or more images.

9. The method of claim 1 , wherein the insulin resistant state is indicated, by the processor of the device, when a second vertical eye movement shown in the second set of one or more images is slowed when compared to a first vertical eye movement test shown in the first set of one or more images.

10. The method of claim 1 , wherein the first set of one or more images is a visual moving image.

11. The method of claim 1 , wherein the second set of one or more images is a visual moving image.

12. The method of claim 1 , further comprising detecting, by the processor of the device, a cognitive disease based on the indicated insulin resistant state.

13. The method of claim 1 , further comprising detecting, by the processor of the device, diabetes mellitus I or II based on the indicated insulin resistant state.

14. The method of claim 1 further comprising accessing the first set of one or more images from a computer-readable storage medium.

15. The method of claim 14 , wherein the computer-readable storage medium is accessed over a network from a remote location.

16. The method of claim 1 further comprising comparing the first set of one or more images to the second set of one or more images.

17. The method of claim 1 , wherein the subsequent time is within 30 minutes of the subject receiving a head trauma.

18. The method of claim 1 , wherein the detected difference between the first change in eye movement and the second change in eye movement comprises an alteration in a structure of the eyes of the subject.

19. The method of claim 18 , wherein the structure of the eyes includes at least one of a retina, blood vessels in the retina, an iris, and a pupil.

Continuity (4)
Continuation 14916754
Provisional Application 61898465 · Oct 31, 2013
Provisional Application 61873822 · Sep 4, 2013
Related Publication 20200405214A1 · Dec 31, 2020
References Cited (41)
US 6090051A · Marshall · 2000 [cited by examiner]
US 9269046B2 · Rothman et al. · 2016 [cited by applicant]
US 9433354B2 · Zelinsky · 2016 [cited by applicant]
US 9460604B1 · Daniel et al. · 2016 [cited by applicant]
US 9798148B2 · Border et al. · 2017 [cited by applicant]
US 9811152B2 · Nortrup et al. · 2017 [cited by applicant]
US 10022049B2 · Klin et al. · 2018 [cited by applicant]
US 10092195B2 · Lovoi et al. · 2018 [cited by applicant]
US 10338091B2 · Wackym · 2019 [cited by applicant]
US 10772554B2 · Kelly · 2020 [cited by examiner]
US 20020099305A1 · Fukushima et al. · 2002 [cited by applicant]
US 20030078513A1 · Marshall · 2003 [cited by examiner]
US 20050101847A1 · Routt et al. · 2005 [cited by applicant]
US 20050288565A1 · Kerr · 2005 [cited by applicant]
US 20060020184A1 · Woods et al. · 2006 [cited by applicant]
US 20060025658A1 · Newman · 2006 [cited by examiner]
US 20060030760A1 · Geiger · 2006 [cited by applicant]
US 20100094161A1 · Kiderman · 2010 [cited by examiner]
US 20100238405A1 · Newman et al. · 2010 [cited by applicant]
US 20110115894A1 · Burnett · 2011 [cited by applicant]
US 20110129133A1 · Ramos et al. · 2011 [cited by applicant]
US 20110245145A1 · Pei · 2011 [cited by examiner]
US 20120122981A1 · Hu · 2012 [cited by examiner]
US 20120323108A1 · Carroll · 2012 [cited by applicant]
US 20130090562A1 · Ryan · 2013 [cited by examiner]
US 20130278899A1 · Waldorf et al. · 2013 [cited by applicant]
US 20160022137A1 · Wetzel · 2016 [cited by examiner]
US 20160146791A1 · Inada · 2016 [cited by examiner]
US 20160192873A1 · Kelly et al. · 2016 [cited by applicant]
KR 20070022670A · 2007 [cited by applicant]
WO 2015057315A1 · 2015 [cited by applicant]
Barlow et al., (2011) “Differences In Change Scores and the Predictive Validity of Three Commonly used Measures Following Concussion in the Middle School and High School Aged Population”, International Journal of Sports… [cited by applicant]
Chui et al., (2007) “Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients”, Diabetes Research and Clinical Practice, 77(2):237-244. [cited by applicant]
Cox et al., (2005) “Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes”, Diabetes Care, 28(1):71-77. [cited by applicant]
Cryer, Philipe., (Apr. 2007) “Hypoglycemia, functional brain failure, and brain death”, The Journal of clinical investigation, 117(4):868-870. [cited by applicant]
Galetta et al., (2011) “The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters”, Neurology, 76(17): 1456-1462. [cited by applicant]
Giza et al., (2001) “The Neurometabolic Cascade of Concussion”, Journal of Athletic Training, 36(3):228-235. [cited by applicant]
Ishii et al., (Aug. 5, 2002) “Construction of the Measurement System and its Experimental Study for Diagnosing Cerebral Functional Disorders Using Eye-Sensing HMD”, Proceedings of the 41st SICE Annual Conference, pp. 12… [cited by applicant]
Iverson et al., (2004) “Cumulative effects of concussion in amateur athletes”, Brain Injury, 18(5):433-443. [cited by applicant]
Watson et al., (2003) “The Role of Insulin Resistance in the Pathogenesis of Alzheimer's Disease: Implications for Treatment”, CNS Drugs, 17(1):27-45. [cited by applicant]
Yoshida et al., (2007) “Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults”, The Journal of nutrition, 137(9):2121-2127. [cited by applicant]
Cited By (1)
US 12,690,802